BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 7.07.2020

Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on research entitled, "Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials."

Source: Federal Register — Food and Drug AdministrationOpen original release →